Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sika reports strong nine-month 2019 results with 15.1% sales growth in local currencies and 10.6% EBIT growth. The company announced key acquisitions including Parex and Crevo-Hengxin, and opened five new factories across Senegal, Egypt, Qatar, Serbia, and Cameroon. Management provided 2019 full-year outlook of over CHF 8 billion in sales with double-digit EBIT growth.
presentation
investor_presentation
29 Pages
Unknown
Teva Pharmaceutical Industries Investor Presentation — November 2020
investor_presentationinvestor_presentation
36 Pages
Teva Pharmaceutical Industries